Emergent BioSolutions (NYSE:EBS – Get Free Report) declared that its board has approved a share repurchase plan on Monday, March 31st, RTT News reports. The company plans to buyback $50.00 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback